Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
A pharmacodynamic study of the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in metastatic colorectal cancer patients. [electronic resource] by
- Daneshmand, Manijeh
- Parolin, Doris A E
- Hirte, Holger W
- Major, Pierre
- Goss, Glenwood
- Stewart, David
- Batist, Gerald
- Miller, Wilson H
- Matthews, Sarah
- Seymour, Lesley
- Lorimer, Ian A J
Producer: 20040420
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 9
Availability: No items available.
|
|
|
18.
|
|
|
|
19.
|
A phase II trial of ZD1839 (Iressa) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancer. [electronic resource] by
- Mackenzie, Mary J
- Hirte, Holger W
- Glenwood, Goss
- Jean, Maroun
- Goel, Rakesh
- Major, Pierre P
- Miller, Wilson H
- Panasci, Lawrence
- Lorimer, Ian A J
- Batist, Gerald
- Matthews, Sarah
- Douglas, Lynn
- Seymour, Lesley
Producer: 20050614
In:
Investigational new drugs vol. 23
Availability: No items available.
|
|
|
20.
|
PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1. [electronic resource] by
- Gont, Alexander
- Hanson, Jennifer E L
- Lavictoire, Sylvie J
- Parolin, Doris A
- Daneshmand, Manijeh
- Restall, Ian J
- Soucie, Mathieu
- Nicholas, Garth
- Woulfe, John
- Kassam, Amin
- Da Silva, Vasco F
- Lorimer, Ian A J
Producer: 20140607
In:
Oncotarget vol. 4
Availability: No items available.
|